Viking Therapeutics (VKTX) Misses Q1 EPS by 6c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.23), $0.06 worse than the analyst estimate of ($0.17).

At March 31, 2017, Viking held cash, cash equivalents and investments totaling $12.3 million. As of April 30, 2017, Viking had 23,925,425 shares of common stock outstanding.

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Cognyte Software (CGNT) Misses Q1 EPS by 5c ; Offers Guidance
• Veeva Systems (VEEV) Tops Q1 EPS by 10c, Offers Guidance